Shares of Cadila Healthcare will be in focus. Zydus Cadila has received the tentative approval from the USFDA to market Apremilast Tablets (US RLD— Otezla) 10 mg, 20 mg, and 30 mg. This medication is used to treat a certain type of arthritis (psoriatic arthritis) and a certain type of skin condition (moderate to severe plaque psoriasis). t is also used to treat mouth sores in people who have Behcet's disease, a type of inflammatory disorder and helps to reduce the pain and improve the healing of these mouth sores. Unichem Laboratories announced that it has received ANDA approval for its Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg, and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bristol-Myers Squibb Company (BMS), Buspar Tablets, 5 mg, 10 mg, 15 mg, and 30 mg. Tata Motors said that the board approved committee has approved allotment of 5000 Rated, Listed, Unsecured, Redeemable, Non-Convertible Debentures (NCDs) E28-A Series of face value Rs 10 lakh each, at par, aggregating to Rs 500 crore in three tranches, on private placement basis. Hinduja Global Solutions said that Hinduja Global Solutions UK, a subsidiary of the company which holds 57% equity interest in Element Solutions LLC, USA has, acquired an additional 14.33% equity interest in the Element Solutions LLC, USA in accordance with the purchase agreement entered on 29 March 2018. HIL said the company has added additional capacities and commenced the production of its CpVC, UpVC and 'SWR (Soil, Waste & Rain) Pipes at its plant located at Thimmapur, Telangana. Asian Oilfield Services has entered into a Share Purchase Agreement dated 15 November 2019 for acquisition of 51% of equity share capital of Optimum Oil & Gas from its existing shareholder. The company currently holds 23% of equity share capital of Optimum. On completion of all closing formalities, Optimum will become a subsidiary of the company with 74% holding. Powered by Capital Market - Live News |